A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.
Buchanan RW; Davis M; Goff D; Green MF; Keefe RS; Leon AC; Nuechterlein KH; Laughren T; Levin R; Stover E; Fenton W; Marder SR; Schizophrenia Bulletin, 2005, vol. 31, issue 1, p 5, ISSN 05867614. ISBN 05867614.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef